06Feb

Shift to Paradigm™ Low-Retention Tips

Alpha-Lab

Paradigm tips administer a virtually clean sample release, guaranteeing that you’ll spend minimal time waiting for the last drop to fall from the tip. Maintain complete control, even when you’re working with smaller volumes, without compromising the accuracy of your pipetting.

 

The innovation begins with a proprietary resin that ensures the sample will not bind to the tip so it is dispensed completely. Physical design characteristics like thin walls and a finely tapered tip point, facilitate sample release and eliminate the need to touch off the pipette tip.

 

The Paradigm™ low-retention range of non-filter reload, and filter tips featuring Aerogard® technology, truly epitomises the perfect pipetting experience. Due to their Universal design, the tips are compatible with a variety of popular pipette brands and models, including the alpha+ range of pipettes.

 

Choose Paradigm for precision and accuracy whilst reducing the loss of your precious samples. Get 30% off these new low retention tips from Alpha Laboratories using offer code LV204 (offer valid until the end of April).

 

For further information please visit www.alphalabs.co.uk/paradigm or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk  

Related

Safe, Easy Serum Vial Transport System New Single Serum (or Paediatric Blood Tube) Pack Extends SpeciSafe® Range

SpeciSafe® secondary packaging containers provide a safe, convenient and economical solution for UN3...

Read More >

BBI Solutions demonstrates internal antibody development capabilities while expanding their infectious disease reagent suite

BBI Solutions has released four new antibodies specific for the HIV-1 p24 capsid protein. The antibo...

Read More >

Evaluation studies confirm improved oncology patient pathways through HORIBA Medical’s new POC haematology analyser

Yumizen H500 full blood count analyser demonstrates exceptional correlation with larger laboratory-b...

Read More >

MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

Partnership aimed at the development of molecular diagnostic assays on Biocartis’ fully automated I...

Read More >

In Brief This Week: VolitionRx, Bio-Techne, Biocept, Meridian Bioscience, and More

NEW YORK (360Dx) – VolitionRx reported a second quarter net loss of $3.5 million, or $.13 per share...

Read More >

Abingdon Health and DCN Diagnostics partner on commercialisation of AppDx m-Health technology

Abingdon Health and DCN Diagnostics have announced a commercial partnership to provide Abingdon Heal...

Read More >